Jens Juul Holst

Jens Juul Holst

Professor


  1. 2000
  2. Published

    Tachykinins in the porcine pancreas: potent exocrine and endocrine effects via NK-1 receptors

    Schmidt, P. T., Tornøe, K., Poulsen, Steen Seier, Nygaard, T. & Holst, Jens Juul, 2000, In: Pancreas. 20, p. 241-247

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Tachykinins in the regulation of gastric motility and secretion

    Schmidt, P. T. & Holst, Jens Juul, 2000, In: Review Cellular and Molecular Life Sciences. 57, p. 579-588

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans

    Flint, A., Raben, A., Rehfeld, J. F., Holst, Jens Juul & Astrup, A., 2000, In: International Journal of Obesity. 24, p. 288-298

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 1999
  6. Published

    Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre

    Thulesen, J., Hartmann, Bolette, Nielsen, C., Holst, Jens Juul & Poulsen, Steen Seier, Nov 1999, In: Gut. 45, 5, p. 672-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine

    Hansen, L., Deacon, Carolyn F., Ørskov, Cathrine & Holst, Jens Juul, Nov 1999, In: Molecular Endocrinology. 140, 11, p. 5356-63 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2

    Damholt, A. B., Buchan, A. M., Holst, Jens Juul & Kofod, H., Oct 1999, In: Endocrinology. 140, 10, p. 4800-8 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Treatment of Type 2 diabetes mellitus based on glucagon-like peptide-1

    Holst, Jens Juul, Sep 1999, In: Expert Opinion on Investigational Drugs. 8, 9, p. 1409-15 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Glucagon-like peptide-1: a basis for new approaches to the management of diabetes

    Deacon, Carolyn F., Holst, Jens Juul & Carr, R. D., Mar 1999, In: Drugs of Today. 35, 3, p. 159-70 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Advances in non-peptide glucagon receptor antagonist

    Madsen, P., Knudsen, L. B., Brand, C. L. & Holst, Jens Juul, 1999, In: Curr. Pharm Design. 5, p. 683-691

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients

    Toft-Nielsen, M. B., Madsbad, S. & Holst, Jens Juul, 1999, In: Diabetes Care. 22, p. 1137-1143

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207